EvidenceDPreliminaryVery uncertain: animal or cell studies, or studies in people with several serious weaknesses.
Probably not for healthy people with no symptoms. Scans found cancer in about 1 in 64 people, often turned up harmless findings, and no study shows people live longer or healthier.
Who it's for
No healthy group has a clear benefit; doctors use it for specific cancers.
What to expect
About 1.6 cancers found per 100 scans; no proven longer life.
Watch out for
False alarms leading to extra tests, procedures and cost.
Few healthy people have a cancer found by whole-body MRI
The dot shows the share of scanned people with confirmed cancer and the line shows the range it could plausibly fall in.
← BetterWorse →
No difference
Pooled result from 10 studies1.57 (1.22 to 2.03)Clear worsening
00.511.52
% of people with confirmed cancer
Few healthy people have a cancer found by whole-body MRI
The American College of Radiology does not recommend total-body MRI screening for people with no symptoms, risk factors or family history of disease. It notes there is no documented evidence that the scans are cost-efficient or prolong life1Guideline · 2023ACR Statement on Screening Total Body MRIThe ACR is concerned that such scans will find numerous non-specific findings that do not ultimately improve health but lead to unnecessary follow-up tests and procedures, and significant expense.American College of Radiology. It warns that scans find many non-specific findings that lead to unnecessary follow-up tests1Guideline · 2023ACR Statement on Screening Total Body MRIThe ACR is concerned that such scans will find numerous non-specific findings that do not ultimately improve health but lead to unnecessary follow-up tests and procedures, and significant expense.American College of Radiology.
What the studies show
A review that pooled 10 studies of 9,024 people without symptoms found cancer confirmed in 1.57% of scans. Most studies had a moderate to serious risk of bias, and the authors cite frequent incidental findings and no long-term outcome or cost data2Meta-analysis · 2026 · 9,024 peopleWhole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis.Although WB-MRI shows potential as an opportunistic non-invasive cancer detection tool, modest detection rates, frequent incidental findings, unstandardized protocols, and lack of long-term outcome or cost-effectiveness data limit its current clinical utility.Eur Radiol.
A 2010 review reached a similar view. Scanning without a medical reason is "decidedly inadvisable" given a yield below 2% and no proof of cost-effectiveness6Review · 2010The uses and limitations of whole-body magnetic resonance imaging.Despite these encouraging results, undirected screening by WB-MRI without an appropriate indication, as is currently being practiced in many institutions, is decidedly inadvisable in view of its predicted diagnostic yield below 2% and the lack of evidence for its cost-effectiveness.Dtsch Arztebl Int. It has not been shown to extend survival and carries a risk of false positives6Review · 2010The uses and limitations of whole-body magnetic resonance imaging.Despite these encouraging results, undirected screening by WB-MRI without an appropriate indication, as is currently being practiced in many institutions, is decidedly inadvisable in view of its predicted diagnostic yield below 2% and the lack of evidence for its cost-effectiveness.Dtsch Arztebl Int.
In 148 healthy volunteers (median age 36), 29% had an abnormal scan. About 13% had a finding of clinical significance7Observational study · 2009 · 148 peopleIncidental findings in healthy control research subjects using whole-body MRI.This study showed that more than one quarter of healthy volunteers have MR-demonstrable abnormalities. There was an increased risk of such findings in obese patients. This has ethical and financial implications for future imaging research, particularly with respect to informed consent and follow-up of those with…Eur J Radiol. Findings rose with age and body weight, and obese people had about 5 times the risk of an incidental abnormality7Observational study · 2009 · 148 peopleIncidental findings in healthy control research subjects using whole-body MRI.This study showed that more than one quarter of healthy volunteers have MR-demonstrable abnormalities. There was an increased risk of such findings in obese patients. This has ethical and financial implications for future imaging research, particularly with respect to informed consent and follow-up of those with…Eur J Radiol.
A Cochrane review is underway to test whether whole-body MRI or CT screening reduces illness and death in adults without symptoms3Systematic review · 2026Whole-body magnetic resonance imaging (MRI) or computed tomography (CT) screening for reducing morbidity and mortality from multiple diseases in asymptomatic adults.OBJECTIVES: This is a protocol for a Cochrane review (intervention). The objectives are as follows: To evaluate the benefits and harms of whole-body magnetic resonance imaging (MRI) or computed tomography (CT) scans for screening in asymptomatic adults, compared with no intervention, usual care, or alternative…Cochrane Database Syst Rev. Its results aren't yet available.
Where cancer is already suspected, whole-body MRI performs well. In 28 patients with cancer, it detected 94% of bone metastases, versus 78% for PET-CT5Clinical trial · 2007 · 28 peopleScreening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.In conclusion, WB-MRI and FDG-PET-CT are robust imaging modalities for a systemic screening for metastatic bone disease. PAT allows WB-MRI bone marrow screening at high spatial resolution and with a diagnostic accuracy superior to PET-CT.Eur Radiol. That small study does not apply to healthy people.
The 1.57% figure is an average across studies. It does not say how likely cancer is in any one person, and it counts cancers found, not lives improved.
Key studies
Study
Who
What it found
Review of 10 studies, 20262Meta-analysis · 2026 · 9,024 peopleWhole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis.Although WB-MRI shows potential as an opportunistic non-invasive cancer detection tool, modest detection rates, frequent incidental findings, unstandardized protocols, and lack of long-term outcome or cost-effectiveness data limit its current clinical utility.Eur Radiol
9,024 adults without symptoms
Cancer found in 1.57%; high rate of incidental findings
Study following people, 20097Observational study · 2009 · 148 peopleIncidental findings in healthy control research subjects using whole-body MRI.This study showed that more than one quarter of healthy volunteers have MR-demonstrable abnormalities. There was an increased risk of such findings in obese patients. This has ethical and financial implications for future imaging research, particularly with respect to informed consent and follow-up of those with…Eur J Radiol
148 healthy volunteers
29% abnormal scans; 13% clinically significant
Review, 20106Review · 2010The uses and limitations of whole-body magnetic resonance imaging.Despite these encouraging results, undirected screening by WB-MRI without an appropriate indication, as is currently being practiced in many institutions, is decidedly inadvisable in view of its predicted diagnostic yield below 2% and the lack of evidence for its cost-effectiveness.Dtsch Arztebl Int
Adults, mixed studies
No survival benefit shown; false positives; yield below 2%
Trial, 20075Clinical trial · 2007 · 28 peopleScreening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.In conclusion, WB-MRI and FDG-PET-CT are robust imaging modalities for a systemic screening for metastatic bone disease. PAT allows WB-MRI bone marrow screening at high spatial resolution and with a diagnostic accuracy superior to PET-CT.Eur Radiol
28 patients with cancer
MRI found 94% of bone metastases; PET-CT 78%
Safety
MRI uses no ionizing radiation6Review · 2010The uses and limitations of whole-body magnetic resonance imaging.Despite these encouraging results, undirected screening by WB-MRI without an appropriate indication, as is currently being practiced in many institutions, is decidedly inadvisable in view of its predicted diagnostic yield below 2% and the lack of evidence for its cost-effectiveness.Dtsch Arztebl Int. The main harm is false positives and incidental findings that trigger more tests and procedures, plus expense1Guideline · 2023ACR Statement on Screening Total Body MRIThe ACR is concerned that such scans will find numerous non-specific findings that do not ultimately improve health but lead to unnecessary follow-up tests and procedures, and significant expense.American College of Radiology,2Meta-analysis · 2026 · 9,024 peopleWhole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis.Although WB-MRI shows potential as an opportunistic non-invasive cancer detection tool, modest detection rates, frequent incidental findings, unstandardized protocols, and lack of long-term outcome or cost-effectiveness data limit its current clinical utility.Eur Radiol,6Review · 2010The uses and limitations of whole-body magnetic resonance imaging.Despite these encouraging results, undirected screening by WB-MRI without an appropriate indication, as is currently being practiced in many institutions, is decidedly inadvisable in view of its predicted diagnostic yield below 2% and the lack of evidence for its cost-effectiveness.Dtsch Arztebl Int.
What we don't know
Whether screening healthy people reduces cancer deaths or extends life. No trial has tested this3Systematic review · 2026Whole-body magnetic resonance imaging (MRI) or computed tomography (CT) screening for reducing morbidity and mortality from multiple diseases in asymptomatic adults.OBJECTIVES: This is a protocol for a Cochrane review (intervention). The objectives are as follows: To evaluate the benefits and harms of whole-body magnetic resonance imaging (MRI) or computed tomography (CT) scans for screening in asymptomatic adults, compared with no intervention, usual care, or alternative…Cochrane Database Syst Rev.
Whether certain high-risk groups, such as those with strong family history, benefit. The studies of people without symptoms excluded them2Meta-analysis · 2026 · 9,024 peopleWhole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis.Although WB-MRI shows potential as an opportunistic non-invasive cancer detection tool, modest detection rates, frequent incidental findings, unstandardized protocols, and lack of long-term outcome or cost-effectiveness data limit its current clinical utility.Eur Radiol.
Written by AI from the studies listed, without review by a clinician, and graded with the GRADE method. It can be wrong, so check the studies it cites. Education, not medical advice.